| __timestamp | ACADIA Pharmaceuticals Inc. | BioMarin Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 302156000 |
| Thursday, January 1, 2015 | 90804000 | 402271000 |
| Friday, January 1, 2016 | 186456000 | 476593000 |
| Sunday, January 1, 2017 | 255062000 | 554336000 |
| Monday, January 1, 2018 | 265758000 | 604353000 |
| Tuesday, January 1, 2019 | 325638000 | 680924000 |
| Wednesday, January 1, 2020 | 388661000 | 737669000 |
| Friday, January 1, 2021 | 396028000 | 759375000 |
| Saturday, January 1, 2022 | 369090000 | 854009000 |
| Sunday, January 1, 2023 | 402466000 | 937300000 |
| Monday, January 1, 2024 | 1009025000 |
Data in motion
In the competitive landscape of pharmaceuticals, understanding spending patterns is crucial. Over the past decade, BioMarin Pharmaceutical Inc. and ACADIA Pharmaceuticals Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, BioMarin's SG&A expenses surged by approximately 210%, reflecting its aggressive growth strategy. In contrast, ACADIA's expenses increased by about 1,130%, indicating a rapid expansion phase.
These trends underscore the strategic priorities of each company, with BioMarin focusing on steady growth and ACADIA on rapid expansion.
Selling, General, and Administrative Costs: Sanofi vs ACADIA Pharmaceuticals Inc.
Bristol-Myers Squibb Company or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
BioMarin Pharmaceutical Inc. or Sarepta Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for BioMarin Pharmaceutical Inc. and Walgreens Boots Alliance, Inc.
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Alpine Immune Sciences, Inc.
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs TG Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Rhythm Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Comparing SG&A Expenses: BioMarin Pharmaceutical Inc. vs Novavax, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and ACADIA Pharmaceuticals Inc.
Who Optimizes SG&A Costs Better? Xenon Pharmaceuticals Inc. or ACADIA Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and MiMedx Group, Inc.